Oral omecamtiv mecarbil: Phase II ongoing

Cytokinetics said a data monitoring committee recommended continuation of the double-blind, placebo-controlled, dose-escalation, international Phase II COSMIC-HF trial evaluating twice-daily omecamtiv...